SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-23-082080
Filing Date
2023-07-18
Accepted
2023-07-18 17:23:08
Documents
5

Document Format Files

Seq Description Document Type Size
1 POS AM tm2321501d1_posam.htm POS AM 705923
2 EXHIBIT 23.1 tm2321501d1_ex23-1.htm EX-23.1 2499
3 GRAPHIC tm2317766d1_posamsp1img001.jpg GRAPHIC 3360
4 GRAPHIC tm2317766d1_posamimg01.jpg GRAPHIC 10915
5 GRAPHIC tm2317766d1_posamsp4img002.jpg GRAPHIC 3573
  Complete submission text file 0001104659-23-082080.txt   734580
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-261888 | Film No.: 231095072
SIC: 2836 Biological Products, (No Diagnostic Substances)